The Indian pharmaceutical and healthcare sector is expected to see moderate revenue growth, with EBITDA margins remaining flat, in the March quarter, according to a brokerage report by HDFC Securitie…...
Source: The Times of India |
Category: Banking |
Published: 6 days ago